![Richard Hague](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Hague
Vorstandsvorsitzender bei
PolarityTE MD, Inc.
Profil
Richard Hague is currently Chief Executive Officer at PolarityTE MD, Inc. Formerly, Mr. Hague was President, Chief Executive Officer & Director at RegenETP, Inc. from 2023 to 2025.
Mr. Hague was Chief Commercial Officer at Anika Therapeutics, Inc. from 2015 to 2019.
Mr. Hague served as Vice President-Sales & Marketing at TEI Medical, Inc. from 2004 to 2015.
Mr. Hague was VP-Sales, Marketing & Commercial Operations at Sanofi UK from 2011 to 2014.
Mr. Hague was Senior Director at Genzyme Biosurgery Corp.
from 2001 to 2005.
Mr. Hague completed undergraduate studies at the University of Connecticut.
Aktive Positionen von Richard Hague
| Unternehmen | Position | Beginn |
|---|---|---|
PolarityTE MD, Inc.
 PolarityTE MD, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops and commercializes regenerative tissue products and biomaterials | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Richard Hague
| Unternehmen | Position | Ende |
|---|---|---|
| REGENETP, INC. | Vorstandsvorsitzender | 01.02.2025 |
| ANIKA THERAPEUTICS, INC. | Corporate Officer/Principal | 05.04.2019 |
TEI Medical, Inc.
 TEI Medical, Inc. BiotechnologyHealth Technology Provides an ideal environment to support cellular repopulation and revascularization processes | Vertrieb & Marketing | 01.10.2015 |
Sanofi UK
 Sanofi UK Pharmaceuticals: MajorHealth Technology Manufactures and markets healthcare products | Vertrieb & Marketing | 01.01.2014 |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Develops and manufactures biotherapeutic and biomaterial products | Direktor/Vorstandsmitglied | 01.01.2005 |
Ausbildung von Richard Hague
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Anika Therapeutics, Inc.
 Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
RegenETP, Inc.
 RegenETP, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes regenerative tissue products & biomaterials | Health Technology |
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Develops and manufactures biotherapeutic and biomaterial products | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TEI Medical, Inc.
TEI Medical, Inc. BiotechnologyHealth Technology Provides an ideal environment to support cellular repopulation and revascularization processes | Health Technology |
Sanofi UK
Sanofi UK Pharmaceuticals: MajorHealth Technology Manufactures and markets healthcare products | Health Technology |
PolarityTE MD, Inc.
PolarityTE MD, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops and commercializes regenerative tissue products and biomaterials | Health Technology |
